Article info
Basic Science
Proteasome Inhibitor MG132 Enhances Sensitivity to Cisplatin on Ovarian Carcinoma Cells In Vitro and In Vivo
- Address correspondence and reprint requests to Zhilan Peng, MD, Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu 610041, China. E-mail: guona507{at}aliyun.com.
Citation
Proteasome Inhibitor MG132 Enhances Sensitivity to Cisplatin on Ovarian Carcinoma Cells In Vitro and In Vivo
Publication history
- Received December 9, 2015
- Accepted February 4, 2016
- First published June 1, 2016.
Online issue publication
June 01, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2016 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.